Tag Archives: COI

Everything you wanted to know about conflicts of interest (even if you weren’t afraid to ask)

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: Sanofi Pasteur via Flickr

The May 2 special issue of JAMA is one to bookmark, because its theme is integral to the work of all journalists: reporting on conflicts of interest (COI). And the best part? The whole thing is free to the public — no paywalls.

As much as covering medical research is making sense of the numbers — statistics, p values, absolute risk, the number needed to treat and the rest — it’s also about good, old-fashioned journalism when it looking at all angles of a story. Continue reading

Check out your sources for conflicts of interest

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

GraphicStock

GraphicStock

It doesn’t take long for many journalists to end up on a slew of PR and marketing lists. Pitch emails roll in 24/7 to promote a product, announce a new study, suggest a story idea or offer up an expert to comment on the pitches or a future story.

Most of these emails end up in the trash, opened or not, but the daily influx occasionally contains a few gems. Continue reading

Freelancers face unique conflict-of-interest dilemmas

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Yan Arief Purwanto. (Creative Commons license)

Photo: Yan Arief Purwanto via Flickr

Previously, Covering Health has addressed two kinds of potential conflicts of interest that health journalists should watch out for: those of journal article authors and those related to sponsors of journalist trips or other training opportunities.

For freelancers, there’s yet another COI maze to navigate: ensuring that work for one client doesn’t create a conflict for another, present or future.

This sounds simple enough: Don’t cover the same research for two competitors, for example. But in today’s freelance ecosystem, avoiding these conflicts has become more complex, especially with the various types of clients freelancers might have. Continue reading

Scientific journals squabble over conflict-of-interest policies

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

doctor-with-megaphone-and-dollar-signA game of inside baseball is being played between two of the most venerated medical journals, and journalists may want to be sure they have a seat near the dugout. The game centers on one of the most important aspects of reporting on medical studies: identifying and making sense of researchers’ potential financial conflicts of interest.

In nearly every medical study, usually somewhere near the end or on the bottom of the first page, the authors declare any conflicts of interest or disclosures they may have that relate to the topic of the study. For editorials and commentaries, authors include the same, though many high-impact journals do not publish review articles and similar viewpoint-based papers by authors who have real or perceived conflicts of interest. Continue reading

Australian journal says no to pharma ads

Andrew Van Dam

About Andrew Van Dam

Andrew Van Dam of The Wall Street Journal previously worked at the AHCJ offices while earning his master’s degree at the Missouri School of Journalism, and he has blogged for Covering Health ever since.

Emergency Medicine Australasia, an Australia-based medical journal, has declared that it will no longer accept paid advertisements from pharmaceutical companies.

ozImage by acediscovery via Flickr

The journal’s editors announced their decision in an editorial, and we learned about it from Pharmalot’s Ed Silverman. In the editorial, the editors say they’re drawing a line in the sand and all but dare other publications to join them. Here’s Silverman with the how-and-why:

The ban followed discussions with other emergency medicine specialists, who worried aloud that advertised drugs were supported by evidence that was neither “of reasonable quality, nor independent.” There were cases of “dubious and unethical” research practices by pharma, including ghostwriting. And academics may face pressure to withhold negative research, which could “inflate views of the efficacy” of heavily promoted drugs.

For more, refer to this AAP story. In this case, the acronym refers to the Australian Associated Press, not the physician group. In Australia, medical journals are one of the only places where pharmaceutical advertising is legal.